Search research articles
Contact Us
Filters
Showing results (311-320 of 339) with videos related to
Page
of 34
Sort By:
Molecular Metabolism
|
April 1, 2020
Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis
Feng Shi, Ya He, Jiangjiang Li, et al.
NPJ Precision Oncology
|
March 3, 2021
Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replication
Yueshuo Li, Feng Shi, Jianmin Hu, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 3, 2015
Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin
Yira Bermudez, Steven P Stratton, Clara Curiel-Lewandrowski, et al.
Cancer Letters
|
June 4, 2016
EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma
Jingchen Lu, Min Tang, Hongde Li, et al.
Molecular Cancer Therapeutics
|
February 28, 2018
Targeting PRPK Function Blocks Colon Cancer Metastasis
Tatyana Zykova, Feng Zhu, Lei Wang, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 31, 2013
A derivative of chrysin suppresses two-stage skin carcinogenesis by inhibiting mitogen- and stress-activated kinase 1
Haidan Liu, Joonsung Hwang, Wei Li, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
July 8, 2018
The Ashitaba (<i>Angelica keiskei</i>) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K
Tianshun Zhang, Qiushi Wang, Mangaladoss Fredimoses, et al.
Experimental Dermatology
|
April 29, 2017
PKCι is a target of 7,8,4'-trihydroxyisoflavone for the suppression of UVB-induced MMP-1 expression
Tae-Gyu Lim, Yoon-A Kim, Jong-Eun Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 15, 2017
RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth
Ke Yao, Cong Peng, Yuwen Zhang, et al.
Molecular Cancer Therapeutics
|
March 29, 2013
Discovery of the novel mTOR inhibitor and its antitumor activities in vitro and in vivo
Hua Xie, Mee-Hyun Lee, Feng Zhu, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 339) with videos related to
Sort By:
Page
of 34
Molecular Metabolism
|
April 1, 2020
Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis
Feng Shi, Ya He, Jiangjiang Li, et al.
NPJ Precision Oncology
|
March 3, 2021
Stabilization of p18 by deubiquitylase CYLD is pivotal for cell cycle progression and viral replication
Yueshuo Li, Feng Shi, Jianmin Hu, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 3, 2015
Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin
Yira Bermudez, Steven P Stratton, Clara Curiel-Lewandrowski, et al.
Cancer Letters
|
June 4, 2016
EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma
Jingchen Lu, Min Tang, Hongde Li, et al.
Molecular Cancer Therapeutics
|
February 28, 2018
Targeting PRPK Function Blocks Colon Cancer Metastasis
Tatyana Zykova, Feng Zhu, Lei Wang, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
October 31, 2013
A derivative of chrysin suppresses two-stage skin carcinogenesis by inhibiting mitogen- and stress-activated kinase 1
Haidan Liu, Joonsung Hwang, Wei Li, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
July 8, 2018
The Ashitaba (<i>Angelica keiskei</i>) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K
Tianshun Zhang, Qiushi Wang, Mangaladoss Fredimoses, et al.
Experimental Dermatology
|
April 29, 2017
PKCι is a target of 7,8,4'-trihydroxyisoflavone for the suppression of UVB-induced MMP-1 expression
Tae-Gyu Lim, Yoon-A Kim, Jong-Eun Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 15, 2017
RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth
Ke Yao, Cong Peng, Yuwen Zhang, et al.
Molecular Cancer Therapeutics
|
March 29, 2013
Discovery of the novel mTOR inhibitor and its antitumor activities in vitro and in vivo
Hua Xie, Mee-Hyun Lee, Feng Zhu, et al.
Page
of 34